Overview


According to FutureWise analysis the market for bioanalytical testing services in 2023 is US$ 4.29 billion, and is expected to reach US$ 8.49 billion by 2031 at a CAGR of 8.90%.

Bioanalytical testing services refer to the analytical services provided to the pharmaceutical, biopharmaceutical, and biotechnology industries to support drug development and research. These services involve the analysis of biological samples, such as urine, blood, and tissue samples, to determine the concentration of drugs, metabolites, and other biological markers in the body. The data obtained from bioanalytical testing is used to assess drug safety, efficacy, and pharmacokinetics and support the drug development and approval processes.

Bioanalytical testing services typically involve a range of analytical techniques, including chromatography, mass spectrometry, immunoassays, and other biochemical methods. These methods are used to quantify drugs and other biomolecules in biological matrices with high sensitivity and specificity. The data obtained from bioanalytical testing is often used to support pharmacokinetic and toxicokinetic studies, as well as clinical trials and post-marketing surveillance of drugs. The use of bioanalytical testing services is critical in drug development and approval processes, as it helps to ensure the safety and efficacy of drugs for human use. These services are also used in the development of new drug delivery systems and formulations, as well as in the identification and characterization of new biomarkers for disease diagnosis and monitoring. Bioanalytical testing services are typically provided by contract research organizations (CROs) and other specialized service providers. These companies have the expertise and equipment necessary to conduct bioanalytical testing in compliance with regulatory guidelines, such as those issued by the US FDA and the EMA.

FutureWise Market Research has published a report that provides an insightful analysis of Bioanalytical Testing Services Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Bioanalytical Testing Services Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • PPD, Inc.
  • ICON Plc
  • Charles River Laboratories International
  • Covance, Inc.
  • IQVIA
  • Syneos Health
  • SGS SA
  • Toxikon
  • Intertek Group Plc
  • Pace Analytical Services LLC

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Bioanalytical Testing Services Market:

  • In February 2022, SGS established a bioanalytical laboratory outfitted with cutting-edge tools and technology, including a Watson LIMS system and WinNonlin software.
  • In November 2021, as part of the growth of its central laboratory services, LabCorp opened a new bioanalytical lab facility in Singapore that will enhance the biomedical ecosystem in that region.

Several factors, including the increasing demand for bioanalytical services in drug development, rising R&D activities in pharmaceutical and biotechnology industries, and increasing outsourcing of bioanalytical testing services, drive the Bioanalytical Testing Services Market. Additionally, the growing prevalence of chronic diseases, such as diabetes, cancer, and cardiovascular diseases, is influencing the demand for new and advanced drugs, further fueling the market's growth. The market is also being influenced by the increasing need for safety and efficacy testing of drugs, as well as the growing regulatory scrutiny of drug development and approval processes. The use of bioanalytical testing services is critical in ensuring that drugs are safe and effective for human use and in complying with regulatory requirements. Moreover, technological advancements and the creation of innovative analytical tools and techniques are also driving the growth of the Bioanalytical Testing Services Market. For instance, the development of liquid chromatography-mass spectrometry (LC-MS) and other high-throughput analytical methods has improved the efficiency and accuracy of bioanalytical testing services.

However, market expansion may be impeded by a variety of causes, such as the high cost of bioanalytical testing services, the lack of skilled professionals, and the stringent regulatory requirements for drug development and approval. Additionally, the COVID-19 pandemic has significantly impacted the market, with disruptions in the supply chain and reduced demand due to the focus on COVID-19 treatment.

By Molecule

  • Small Molecule
  • Large Molecule
    • LC-MS Studies
    • Immunoassays
      • PK
      • ADA
      • Others
    • Others

By Test

  • ADME
    • In-Vivo
    • In-Vitro
  • PK
  • PD
  • Bioavailability
  • Bioequivalence
  • Others

By Workflow

  • Sample Preparation
    • Protein Precipitation
    • Liquid-Liquid Extraction
    • Solid Phase Extraction
  • Sample Analysis
    • Hyphenated technique
    • Chromatographic technique
    • Electrophoresis
    • Ligand Binding Assay
    • Mass Spectrometry
    • Nuclear Magnetic Resonance
  • Other Work flow Processes

By Therapeutic Area

  • Oncology
  • Neurology
  • Metabolic Disorders
  • Hematology
  • Immunology
  • Orthopedics
  • Others

By End-User

  • Pharmaceutical and Biotechnology Companies
  • Contract Development and Manufacturing Organisation
  • Contract Research Organisation
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. Asia-pacific region is expected to register the highest CAGR during the forecast period. This may be mostly attributable to the rising need for bioanalytical services with many ongoing research projects and clinical trials, which will likely fuel the market expansion in this region. In the Bioanalytical Testing Services Market, the Asia Pacific region is expected to develop at the fastest rate, owing to the increasing demand for bioanalytical testing services in emerging economies such as China, India, and Japan. The increasing healthcare expenditure, rising prevalence of chronic diseases, and government initiatives to promote drug development and approval are expected to drive the growth of the market in the region.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Bioanalytical Testing Services Market By Molecule, By Test, By Workflow, By Therapeutic Area, By End-User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions - North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Bioanalytical Testing Services Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Bioanalytical Testing Services Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Bioanalytical Testing Services Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Bioanalytical Testing Services Market, By Molecule Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Small Molecule
        2. Large Molecule
         2.1. LC-MS Studies
         2.2. Immunoassays
          2.2.1. PK
          2.2.2. ADA
          2.2.3. Others
         2.3. Others

  • 8.   Bioanalytical Testing Services Market, By Test Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. ADME
         1.1. In-Vivo
         1.2. In-Vitro
        2. PK
        3. PD
        4. Bioavailability
        5. Bioequivalence
        6. Others

  • 9.   Bioanalytical Testing Services Market, By Workflow Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Sample Preparation
         1.1. Protein Precipitation
         1.2. Liquid-Liquid Extraction
         1.3. Solid Phase Extraction
        2. Sample Analysis
         2.1. Hyphenated technique
         2.2. Chromatographic technique
         2.3. Electrophoresis
         2.4. Ligand Binding Assay
         2.5. Mass Spectrometry
         2.6. Nuclear Magnetic Resonance
        3. Other Workflow Processes

  • 10.  Bioanalytical Testing Services Market, By Therapeutic Area Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Oncology
        2. Neurology
        3. Metabolic Disorders
        4. Hematology
        5. Immunology
        6. Orthopedics
        7. Others

  • 11.   Bioanalytical Testing Services Market, By End-User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Pharmaceutical and Biotechnology Companies
        2. NContract Development and Manufacturing Organisation
        3. Contract Research Organisation
        4. Others

  • 12.   North America Bioanalytical Testing Services Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 13.   Latin America Bioanalytical Testing Services Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 14.   Europe Bioanalytical Testing Services Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 15.   Asia Pacific Bioanalytical Testing Services Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 16.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 17.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 18.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. PPD, Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. ICON Plc
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Charles River Laboratories International
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Covance, Inc.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. IQVIA
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Syneos Health
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. SGS SA
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Toxikon
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Intertek Group Plc
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Pace Analytical Services LLC
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 19.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 20.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients